FindTrial
Sign In

Effects of Auriculotherapy and Midazolam in anxiety control in patients submitted to extraction of third molars

Effects of Auriculotherapy and Midazolam in anxiety control in patients submitted to exodontics of third molars

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-67xf25
Enrollment
Unknown
Registered
2016-11-21
Start date
2015-09-30
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety

Interventions

The 30 participants in the research will receive the following treatments: Midazolan 15mg orally, 30min before, associated with placebo auriculoterapia (only coverage of stitches with tape)
And placebo medication, 30min before, associated with mustard seed auriculoterapia, five days before, in a randomized and crossed manner (all patients will receive both treatments, one for each exodon
Drug
Procedure/surgery
Other
E06.892
E03.250
E02.190.204

Sponsors

Universidade Federal de Sergipe - UFS
Lead Sponsor
Universidade Federal de Sergipe - UFS
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: exodontia indication of third molar; asymptomatic; positions and similar surgical difficulties; classified as 2B Pell & Gregory (1942)

Exclusion criteria

Exclusion criteria: under 18 years of age patients; patients classified as ASA III or IV; drug use history for pain or anxiety in the 15 days before the beginning of the study; history of hypersensitivity to drugs, substances or materials used in this experiment; pregnancy or lactation; previous history of pericoronitis

Design outcomes

Primary

MeasureTime frame
Effects of auricular and Midazolam in controlling anxiety in patients undergoing extraction of third molars, verified by the two-way ANOVA test with post-test Bonferroni, from finding a variation of at least 5 % in measurements during surgery.—

Secondary

MeasureTime frame
Secondary outcomes are not expected—

Countries

Brazil

Contacts

Public ContactAndrea Dellovo

Universidade Federal de Sergipe - UFS

deadellovo@hotmail.com+55 (79) 99930 5302

Outcome results

None listed

Source: REBEC (via WHO ICTRP)